{"@id":"https://bioecon.ru/technology/humanized-multi-organoid-co-culture-assays/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://en.bioecon.ru/technology/humanized-multi-organoid-co-culture-assays/","json":"https://en.bioecon.ru/api/v1/technology/humanized-multi-organoid-co-culture-assays/index.json"},"id":"humanized-multi-organoid-co-culture-assays","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/danagreen/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/botanical-solution-inc/","https://bioecon.ru/companies/kilimorgano/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/lidea-seeds/","https://bioecon.ru/companies/rev-genomics/","https://bioecon.ru/companies/caladan-bio/"]},"maturity":8,"name":"Humanized Multi-Organoid Co-Culture Assays","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Primary human progenitor isolation"},{"n":2,"title":"3D organotypic matrix micro-patterning"},{"n":3,"title":"Autologous immune and stromal co-infusion"},{"n":4,"title":"Multiplex phenotypic and secretome readout"}],"summary":"Standardized 3D co-culture platforms integrating primary human organoids with autologous immune cells and stromal fibroblasts under physiological extracellular matrix scaffolds to evaluate multi-tissue therapeutic efficacy, systemic toxicity, and cytokine release.","url":"/technology/humanized-multi-organoid-co-culture-assays/","verified":"2026-11-22"}